Israeli Study Says South African Variant Can 'Break Through' The Pfizer Vaccine
Daily Mail: Mutant South African Covid-19 variant can 'break through' the Pfizer jab, study finds
* Scientists studied 400 people who tested positive at least 14 days after jab
* The variant was eight times more prevalent in those who had two jabs than none
* It was seen in 5.4% of people with 2 doses - but 0.7% of people without any
* Researchers said results suggest the South African variant cannot be combated by the vaccine as well as others
The mutant South African Covid-19 variant can 'break through' the Pfizer jab, a study has found.
Scientists studied 400 people who had tested positive for coronavirus at least 14 days after receiving one or two doses of the jab - and 400 who tested positive with no vaccine.
The variant was eight times more prevalent in those who had two jabs than none. It was seen in 5.4 per cent of people with two doses - but 0.7 per cent of people without any.
Read more ....
WNU Editor: This study still needs to be peered review. But everyone I know who understand vaccines and epidemics/pandemics are telling me the same thing. With time a virus/coronavirus will be able to overcome a vaccine.
More News On an Israeli Study Saying That The South African Variant Can 'Break Through' The Pfizer Vaccine
South African variant can 'break through' Pfizer vaccine, Israeli study says -- Reuters
Israeli Research: Pfizer Vaccine Less Effective Against S. African Variant -- i24 News
Study finds South African variant can ‘break through’ Pfizer-BioNTech vaccine -- The National
South African COVID variant can ‘break through’ Pfizer vaccine: study -- NYPost
Terima kasih karena telah membaca informasi tentang Israeli Study Says South African Variant Can 'Break Through' The Pfizer Vaccine . Silahkan membaca berita lainnya.
Reviewed by Admin Blog
on
10:54 AM
Rating:
